Grolman India Chemical Profile
Key Indicators
- Authorised Capital ₹ 4.55 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.52 Cr
as on 18-07-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -33.31%
(FY 2023)
- Profit 71.55%
(FY 2023)
- Ebitda 62.28%
(FY 2023)
- Net Worth 44.23%
(FY 2023)
- Total Assets -36.06%
(FY 2023)
About Grolman India Chemical
The Corporate was formerly known as Grolman India Chemical Distribution Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.55 Cr and a paid-up capital of Rs 1.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mike Doersam, Andreas Zett, Florian Grolman, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290MH2016FTC288409
- Company No.
288409
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
13 Dec 2016
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Andheri West Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Grolman India Chemical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shukla Shravan  | Managing Director | 13-Dec-2016 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Andreas Zett  | Director | 13-Dec-2016 | Current |
| Mike Doersam | Director | 13-Dec-2016 | Current |
| Florian Grolman | Director | 13-Dec-2016 | Current |
Financial Performance and Corporate Structure Insights of Grolman India Chemical.
Grolman India Chemical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.31% decrease. The company also saw a substantial improvement in profitability, with a 71.55% increase in profit. The company's net worth Soared by an impressive increase of 44.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grolman India Chemical?
In 2022, Grolman India Chemical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Grolman India Chemical?
Unlock and access historical data on people associated with Grolman India Chemical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grolman India Chemical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grolman India Chemical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
